Is Carter's (NYSE:CRI) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Carter's, Inc. (NYSE:CRI) does use debt in its business. But should shareholders be worried about its use of debt?

Advertisement

Why Does Debt Bring Risk?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

Check out our latest analysis for Carter's

How Much Debt Does Carter's Carry?

The image below, which you can click on for greater detail, shows that Carter's had debt of US$497.9m at the end of September 2024, a reduction from US$567.2m over a year. However, because it has a cash reserve of US$175.5m, its net debt is less, at about US$322.4m.

debt-equity-history-analysis
NYSE:CRI Debt to Equity History February 9th 2025

How Healthy Is Carter's' Balance Sheet?

According to the last reported balance sheet, Carter's had liabilities of US$484.1m due within 12 months, and liabilities of US$1.06b due beyond 12 months. Offsetting these obligations, it had cash of US$175.5m as well as receivables valued at US$247.0m due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$1.13b.

This deficit is considerable relative to its market capitalization of US$1.82b, so it does suggest shareholders should keep an eye on Carter's' use of debt. Should its lenders demand that it shore up the balance sheet, shareholders would likely face severe dilution.

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). Thus we consider debt relative to earnings both with and without depreciation and amortization expenses.

Carter's has a low net debt to EBITDA ratio of only 0.88. And its EBIT covers its interest expense a whopping 15.3 times over. So you could argue it is no more threatened by its debt than an elephant is by a mouse. While Carter's doesn't seem to have gained much on the EBIT line, at least earnings remain stable for now. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Carter's can strengthen its balance sheet over time. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

Finally, a business needs free cash flow to pay off debt; accounting profits just don't cut it. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. During the last three years, Carter's produced sturdy free cash flow equating to 72% of its EBIT, about what we'd expect. This free cash flow puts the company in a good position to pay down debt, when appropriate.

Our View

Carter's's interest cover was a real positive on this analysis, as was its conversion of EBIT to free cash flow. On the other hand, its level of total liabilities makes us a little less comfortable about its debt. Considering this range of data points, we think Carter's is in a good position to manage its debt levels. Having said that, the load is sufficiently heavy that we would recommend any shareholders keep a close eye on it. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. We've identified 2 warning signs with Carter's (at least 1 which shouldn't be ignored) , and understanding them should be part of your investment process.

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:CRI

Carter's

Designs, sources, and markets branded childrenswear in the United States and internationally.

Flawless balance sheet average dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7059.1% undervalued
6 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17030.5% undervalued
23 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38026.8% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.5% undervalued
35 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

CJ
WISE logo
cjimi on Wise Group ·

Wise: A Quality Cross-Border Payments Compounder, But Not A Bargain

Fair Value:UK£12.0232.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MI
DEC logo
Miracleworker on Diversified Energy ·

Diversified Energy's Profit Margin Set to Skyrocket 27%

Fair Value:UK£17.42k99.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JU
BBWI logo
julio on Bath & Body Works ·

BBWI VALUATION

Fair Value:US$32.943.1% undervalued
20 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.2% undervalued
124 users have followed this narrative
2 users have commented on this narrative
35 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9719.7% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1926.5% undervalued
46 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative